Search research articles
Contact Us
Filters
Showing results (101-110 of 227) with videos related to
Page
of 23
Sort By:
Transplantation
|
November 15, 1996
Nonprocurement of transplantable organs in a tertiary care hospital: a focus on sociological causes
I Durand-Zaleski, R Waissman, P Lang, et al.
Lancet (London, England)
|
July 17, 1993
Reducing unnecessary laboratory use with new test request form: example of tumour markers
I Durand-Zaleski, J C Rymer, F Roudot-Thoraval, et al.
International Journal of Technology Assessment in Health Care
|
January 1, 1993
Economic assessment of magnetic resonance imaging for inpatients: is it still too early?
I Durand-Zaleski, D Reizine, D Puzin, et al.
Cancer
|
September 10, 1998
Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases
I Durand-Zaleski, S Earlam, C Fordy, et al.
Pharmacoeconomics
|
January 11, 2001
HIV-1 drug resistance genotyping. A review of clinical and economic issues
C Chaix-Couturier, C Holtzer, K A Phillips, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1994
Interleukin-6 biosynthesis in human preovulatory follicles: some of its potential roles at ovulation
V Machelon, D Emilie, A Lefevre, et al.
The British Journal of Dermatology
|
October 10, 1998
Lichen planus following hepatitis B vaccination
M F Ferrando, M S Doutre, M Beylot-Barry, et al.
The Journal of Experimental Medicine
|
March 17, 1997
The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
G Grouard, M C Rissoan, L Filgueira, et al.
American Journal of Perinatology
|
October 1, 1996
Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group
I Durand-Zaleski, N Schlegel, C Blum-Boisgard, et al.
The British Journal of Dermatology
|
June 10, 2000
Cost evaluation of the medical management of neurofibromatosis 1: a prospective study on 201 patients
P Wolkenstein, I Durand-Zaleski, J C Moreno, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 227) with videos related to
Sort By:
Page
of 23
Transplantation
|
November 15, 1996
Nonprocurement of transplantable organs in a tertiary care hospital: a focus on sociological causes
I Durand-Zaleski, R Waissman, P Lang, et al.
Lancet (London, England)
|
July 17, 1993
Reducing unnecessary laboratory use with new test request form: example of tumour markers
I Durand-Zaleski, J C Rymer, F Roudot-Thoraval, et al.
International Journal of Technology Assessment in Health Care
|
January 1, 1993
Economic assessment of magnetic resonance imaging for inpatients: is it still too early?
I Durand-Zaleski, D Reizine, D Puzin, et al.
Cancer
|
September 10, 1998
Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases
I Durand-Zaleski, S Earlam, C Fordy, et al.
Pharmacoeconomics
|
January 11, 2001
HIV-1 drug resistance genotyping. A review of clinical and economic issues
C Chaix-Couturier, C Holtzer, K A Phillips, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1994
Interleukin-6 biosynthesis in human preovulatory follicles: some of its potential roles at ovulation
V Machelon, D Emilie, A Lefevre, et al.
The British Journal of Dermatology
|
October 10, 1998
Lichen planus following hepatitis B vaccination
M F Ferrando, M S Doutre, M Beylot-Barry, et al.
The Journal of Experimental Medicine
|
March 17, 1997
The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
G Grouard, M C Rissoan, L Filgueira, et al.
American Journal of Perinatology
|
October 1, 1996
Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group
I Durand-Zaleski, N Schlegel, C Blum-Boisgard, et al.
The British Journal of Dermatology
|
June 10, 2000
Cost evaluation of the medical management of neurofibromatosis 1: a prospective study on 201 patients
P Wolkenstein, I Durand-Zaleski, J C Moreno, et al.
Page
of 23